SEC Form D · filed April 12, 2018
EyePoint Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Dario S. Paggiarino · WATERTOWN, MAExecLeonard S. Ross · WATERTOWN, MAExecDavid Mazzo · WATERTOWN, MADirectorRonald W. Eastman · Watertown, MADirectorDouglas W. Godshall · Watertown, MADirectorMichael Rogers · WATERTOWN, MADirectorJay Duker · WATERTOWN, MADirectorNancy Lurker · WATERTOWN, MAExec · DirectorJames Barry · WATERTOWN, MADirectorKristine Peterson · WATERTOWN, MADirectorImani Abdullah · SCOTTSDALE, AZDirectorJason R. Roswig · New York, NYDirectorSachin C. Bavishi · New York, NYDirectorJordan Gallacher · Lone Tree, CODirectorJeremy R. Bondy · San Francisco, CADirectorVino Kulhari · Pembroke Pines, FLExecMichael Puopolo · New York, NYExec · DirectorJohn Gillespie · Lone Tree, CODirectorRichard Tallman · San Francisco, CAExecSimon S. Sutton · Chicago, ILDirectorSteven Cruz · Yonkers, NYDirectorVincent Arena · BOULDER, CODirectorLaura Murtagh · BOULDER, CODirectorTodd Steiner · BOULDER, COExecHalle Capital Management LP · New York, NYExecHalle Capital Partners GP LLC · New York, NYDirectorMatthew Rhodes · San Francisco, CADirectorKirsten Green · San Francisco, CADirectorStefan K. Schauss · VANCOUVER, British Columbia, CanadaExec · DirectorGordon K. Neal · VANCOUVER, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗